Sort
51,593 grants matching “hepatitis”
GENETICALLY MODIFIED HEPATOCYTES TO ACHIEVE SUCCESS IN LIVER CELL TRANSPLANTATION
$613,378David A Shafritz · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · DK
Biochemistry of Protein Prenylation
$613,376Michael H Gelb · University Of Washington · R01 · FY2011 · AI
Mechanisms of hepatic innate immune activation by HCV
$613,337Michael J Gale · University Of Washington · R01 · FY2018 · AI
Core 1: Administrative Core
$613,316Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2021 · DA
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
$613,306Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2008 · CA
Role of the innate immune defenses in viral infections
$613,270Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
$613,174Jean-Marc Schwarz · Touro University Of California · R01 · FY2016 · HL
Isolation, characterization, and transplantation of candidate stem cells
$613,083John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Brief Intervention for Drug Misuse for the Emergency Department (BIDMED)
$613,045Roland C Merchant · Rhode Island Hospital · R01 · FY2012 · DA
Combination Gene Therapy for Treatment of Canine Mucopolysaccharidosis Type I
$613,028Raymond Yu Jeang Wang · Children'S Hospital Of Orange County · R01 · FY2024 · HD
Implementation science research on PrEP delivery and costing within MAT and NSP services for PWUD in Uganda
$613,015Renee A. Heffron · University Of Washington · R01 · FY2021 · DA
Molecular pathogenesis of blastomycosis
$612,804Bruce Steven Klein · University Of Wisconsin-Madison · R37 · FY2025 · AI
Developmental Funds
$612,636Scott M Lippman · University Of California, San Diego · P30 · FY2019 · CA
Molecular and Cellular Basis of PCB Developmental Neurotoxicity
$612,589Pamela J Lein · University Of California At Davis · R01 · FY2022 · ES
Improving Hepatitis C Treatment in Injection Drug Users
$612,502Upstate Medical University · R01 · FY2003 · DA
Biochemical and Genetic Markers of Type 2 Diabetes Risk
$612,499Frank B Hu · Brigham And Women'S Hospital · R01 · FY2012 · DK
In search of an HBV cure: novel model systems and targets
$612,444Charles M. Rice · Rockefeller University · R01 · FY2019 · AI
Investigation of management and disease manifestations of viral hepatitis
$612,410Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Investigation of management and disease manifestations of viral hepatitis
$612,410Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Investigation of management and disease manifestations of viral hepatitis
$612,410Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
NEW PROBE AND METHODS FOR CORRELATED LM AND EM
$612,403Roger Y Tsien · University Of California, San Diego · R01 · FY2014 · GM
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care
$612,390Benjamin P Linas · Boston Medical Center · R01 · FY2015 · DA
Psychoeducation for HCV and Alcohol Behaviors
$612,314Carol S North · Ut Southwestern Medical Center · R01 · FY2006 · AA
Disease Management for Chronic Drug Abuse
$612,241Jon Morgenstern Morgenstern · Partnership To End Addiction · R01 · FY2011 · DA
HIV-1 Preintegration Trafficking and Nuclear Localization
$612,217Alan N. Engelman · Dana-Farber Cancer Inst · R01 · FY2024 · AI